rs11635495 - IQCH-AS1
Magnitude 2.2 · 1 study on file
Reported associations
-
Biological and clinical insights from genetics of insomnia symptoms - Unknown journal (n.d.) · Unknown authors · PubMed 30804566
ABSTRACT: Insomnia is a common disorder linked with adverse long-term medical and psychiatric outcomes. The underlying pathophysiological processes and causal relationships of insomnia with disease are poorly understood. Here we identify 57 loci for self-reported insomnia symptoms in the UK Biobank (n = 453,379) and confirm their impact on self-reported insomnia symptoms in the HUNT study (n = 14,923 cases, 47,610 controls), physician-diagnosed insomnia in Partners Biobank (n = 2,217 cases, 14,240 controls), and accelerometer-derived measures of sleep efficiency and sleep duration in the UK Biobank (n = 83,726). Our results suggest enrichment of genes involved in ubiquitin-mediated proteolysis and of genes expressed in multiple brain regions, skeletal muscle, and adrenal gland. Evidence of
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
Insomnia genetic predisposition and management Moderate
Awareness of genetic risk can facilitate earlier clinical recognition and guide preventive or therapeutic strategies for insomnia
Discuss rs11635495 C allele with physician; review sleep history and risk factors
Screening
-
Insomnia symptom screening Moderate
C allele at rs11635495 associates with 1.02-fold increased insomnia risk per allele; baseline assessment enables future monitoring
Annual insomnia screening; maintain sleep diary if symptoms develop